Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Matinas Biopharma Holdings Inc (AMEX: MTNB) closed at $0.18 down -1.43% from its previous closing price of $0.18. In other words, the price has decreased by -$1.43 from its previous closing price. On the day, 1.4 million shares were traded. MTNB stock price reached its highest trading level at $0.188 during the session, while it also had its lowest trading level at $0.1748.
Ratios:
For a deeper understanding of Matinas Biopharma Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.93 and its Current Ratio is at 5.93. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
On January 27, 2020, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $3.Piper Sandler initiated its Overweight rating on January 27, 2020, with a $3 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MTNB now has a Market Capitalization of 44870984 and an Enterprise Value of 28707678. For the stock, the TTM Price-to-Sale (P/S) ratio is 40.79 while its Price-to-Book (P/B) ratio in mrq is 2.02. Its current Enterprise Value per Revenue stands at 26.193 whereas that against EBITDA is -1.228.
Stock Price History:
The Beta on a monthly basis for MTNB is 1.63, which has changed by -0.70166665 over the last 52 weeks, in comparison to a change of 0.22363698 over the same period for the S&P500. Over the past 52 weeks, MTNB has reached a high of $0.89, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is -27.02%, while the 200-Day Moving Average is calculated to be -22.51%.
Shares Statistics:
For the past three months, MTNB has traded an average of 1.55M shares per day and 889040 over the past ten days. A total of 250.82M shares are outstanding, with a floating share count of 243.50M. Insiders hold about 2.92% of the company’s shares, while institutions hold 10.29% stake in the company. Shares short for MTNB as of 1713139200 were 3192030 with a Short Ratio of 2.05, compared to 1710460800 on 1321911. Therefore, it implies a Short% of Shares Outstanding of 3192030 and a Short% of Float of 1.3099999.
Earnings Estimates
The performance of Matinas Biopharma Holdings Inc (MTNB) in the stock market is under the watchful eye of 1.0 analysts actively contributing to its current rating.On average, analysts expect EPS of -$0.03 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.03, while EPS last year was -$0.03. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.03 and low estimates of -$0.03.
Analysts are recommending an EPS of between -$0.12 and -$0.12 for the fiscal current year, implying an average EPS of -$0.12. EPS for the following year is -$0.1, with 1.0 analysts recommending between -$0.1 and -$0.1.
